Penicillin 'allergy' complicates inpatient care

Penicillin 'Allergy' complicates inpatient care

(HealthDay)—Patients with a history of penicillin "allergy," even though that may be inaccurate, spend more time in the hospital and have a greater risk of acquiring antibiotic-associated infections, according to research published in the Journal of Allergy and Clinical Immunology.

Eric Macy, M.D., of the Southern California Permanente Medical Group in San Diego, and Richard Contreras, of the Kaiser Permanente Health Care Program in Pasadena, Calif., conducted a retrospective, matched cohort study involving 51,582 subjects with penicillin "allergy" who were admitted to Kaiser Foundation hospitals in Southern California in 2010 through 2012. Each subject was matched to two control subjects by age, sex, date of admission, and discharge diagnosis.

The researchers found that patients labeled with , compared with control subjects, averaged 0.59 more total hospital days (95 percent confidence interval [CI], 0.47 to 0.71). Case subjects received treatment with significantly more of each of the following antibiotics: fluoroquinolones, clindamycin, and vancomycin. Compared with , case subjects experienced more Clostridium difficile infections (23.4 percent; 95 percent CI, 15.6 to 31.7 percent), methicillin-resistant Staphylococcus aureus infections (14.1 percent; 95 percent CI, 7.1 to 21.6 percent), and vancomycin-resistant Enterococcus infections (30.1 percent; 95 percent CI, 12.5 to 50.4 percent).

"A penicillin 'allergy' history, although often inaccurate, is not a benign finding at hospital admission," the authors write.

The Kaiser Permanente Health Care Program and ALK-Abelló funded the study. Both study authors disclosed financial ties to ALK-Abelló.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Psoriasis tied to 14 other autoimmune diseases

Jun 15, 2012

(HealthDay) -- Patients with psoriasis have significantly higher odds for having at least one of 14 other autoimmune diseases, according to a study published online June 4 in the Journal of the American Ac ...

Stage III/IV melanoma patients at risk for new primaries

Dec 10, 2013

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower ...

Melanoma risk up in IBD independent of biologic therapy

Jan 31, 2014

(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Ga ...

Metformin use doesn't cut incidence of bladder cancer

Feb 11, 2014

(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Recommended for you

Research reveals how lymph nodes expand during disease

13 hours ago

Cancer Research UK and UCL scientists have discovered that the same specialised immune cells that patrol the body and spot infections also trigger the expansion of immune organs called lymph nodes, according to a study published ...

Protecting us from our cells

16 hours ago

Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes ...

User comments